Zou Wan-Wan, Zhu Qi-Kun, Yang Song, Bian En-Ze, Zhuang Wei-Zhong, Cen Jian-Zheng, Gao Qiang
School of Medicine, South China University of Technology, Guangzhou, 510006, China.
Department of Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, China.
J Cardiothorac Surg. 2025 Jul 31;20(1):320. doi: 10.1186/s13019-025-03552-1.
The safety and efficacy of prophylactic corticosteroid administration during the perioperative period of cardiac surgery have undergone extensive and comprehensive examination. In this study, we conducted a bibliometric analysis of publications addressing corticosteroid use in the perioperative period of cardiac surgery, aiming to elucidate the principal research trajectories and emerging trends spanning the past 23 years.
We performed a search in the Web of Science Core Collection for publications related to the application of corticosteroids during the perioperative period of cardiac surgery, spanning from the year 2000 to October 30, 2023. Bibliometric analysis was conducted employing the biblioshiny package in R, VOSviewer, and CiteSpace.
We identified 293 eligible publications concerning corticosteroid use during the perioperative period of cardiac surgery. Publication volume increased significantly in 2001 and 2014. Keyword co-occurrence analysis revealed four primary clusters: cardiopulmonary bypass, systemic inflammatory response, methylprednisolone, and dysfunction. Over recent decades, research focus has shifted from examining how prophylactic corticosteroid use attenuates postoperative inflammation to investigating its potential effects on clinical complications following cardiac surgery.
Considerable heterogeneity in inflammatory response phenotypes among individuals may lead to significant differences in the clinical effectiveness of prophylactic corticosteroid interventions. Thus, developing personalized treatment strategies should become a major focus in future research.
心脏手术围手术期预防性使用皮质类固醇的安全性和有效性已得到广泛而全面的研究。在本研究中,我们对有关心脏手术围手术期使用皮质类固醇的出版物进行了文献计量分析,旨在阐明过去23年的主要研究轨迹和新出现的趋势。
我们在科学网核心合集中搜索了2000年至2023年10月30日期间与心脏手术围手术期应用皮质类固醇相关的出版物。使用R语言中的biblioshiny包、VOSviewer和CiteSpace进行文献计量分析。
我们确定了293篇关于心脏手术围手术期使用皮质类固醇的符合条件的出版物。2001年和2014年的出版物数量显著增加。关键词共现分析揭示了四个主要聚类:体外循环、全身炎症反应、甲泼尼龙和功能障碍。近几十年来,研究重点已从研究预防性使用皮质类固醇如何减轻术后炎症转移到研究其对心脏手术后临床并发症的潜在影响。
个体间炎症反应表型的显著异质性可能导致预防性皮质类固醇干预临床效果的显著差异。因此,制定个性化治疗策略应成为未来研究的主要重点。